lobbying_activities: 1109047

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1109047	7b69af26-6cf6-4853-8f7e-73cc2ace7735	Q2	MEHLMAN CONSULTING, INC.	284950	ASTRAZENECA PHARMACEUTICALS	2011	second_quarter	MMM	Budget issues, including Medicare Part D Rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage. Legislation to address physician payments issues, including SGR and related provisions to Medicare package. Health reform implementation. Independent Payment Advisory Board.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2011-07-11T10:59:49.017000-04:00